Stoke Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Stoke Therapeutics has a total shareholder equity of $159.6M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $228.3M and $68.8M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$201.39m |
Equity | US$159.57m |
Total liabilities | US$68.78m |
Total assets | US$228.34m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0GT's short term assets ($215.3M) exceed its short term liabilities ($30.8M).
Long Term Liabilities: 0GT's short term assets ($215.3M) exceed its long term liabilities ($38.0M).
Debt to Equity History and Analysis
Debt Level: 0GT is debt free.
Reducing Debt: 0GT has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0GT has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 0GT has sufficient cash runway for 1.8 years if free cash flow continues to reduce at historical rates of 26.1% each year.